Johnson & Johnson Upgraded To Outperform From Market Perform At Wells Fargo
October 09, 2017 at 10:13 AM EDT
Wells Fargo analyst Larry Biegelsen upgraded Johnson & Johnson to Outperform and raised his price target for the shares to $149 from $140. The healthcare giant closed Friday up 1c to $133.22.